StockUnited StatesNasdaqGM

ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.29USD

+0.0100 (+0.14%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 7.29

P/E—

Dvd Ind Yld—

P/B15.31

P/S547.4

Curr EV/T12M EBITDA-17.6

Mkt Cap (USD)2.7B

Curr EV (USD)2.5B

Per Share Data

EPS T12M-0.46

DPS—

Bk Val Per Sh0.48

Rev/Sh0.01

Cash/Sh0.61

Curr Shares Out370.9M

FCF/Sh-0.25

Cash Flow Analysis

P/CF-30.6

Curr P/FCF-30.4

CF/NI0.8

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales-1790.3%

Eff Interest Rate5.1%

Growth Potential

Dil EPS 1Y Gr-212.9%

Cap 1Y Gr161.2%

BPS 1Y Gr34.9%

R&D To Sales18.2%

Retention Rate100.0%

Rev 1Y Gr1227.6%

FCF 1Y Gr-25.6%

Assets 1Y Gr83.7%

Profitability

EBITDA-0.1B

EBIT-0.1B

Operating Margin-2447.0%

Pretax Margin-2356.6%

Net Margin-2361.4%

ROA-51.5%

ROE-68.9%

ROC—

Asset Turnover0.02

Structure

Current Ratio8.58

Quick Ratio8.29

Debt/Assets8.7%

Debt/Com Eq13.0%

Net Debt/EBITDA1.21

Tot Debt/Capital11.5%

Gross Margin0.0%

EBIT/Int Exp-103.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.